- Antibodies and HIV: New Evidence (Interview with Ruth Ruprecht, M.D., Ph.D.)
While most antibodies are not effective against HIV, an immunologist has found some that are. This research might be very important for vaccine development, for protecting infants from infection (including from breast milk), and possibly for developing better treatments for persons already infected.
- Danger: Counterfeit Neupogen® (Filgrastim)
A counterfeit drug with no active ingredient is circulating in the United States; it could be a serious health risk to patients. The fake product is easy to recognize, by using instructions and photos on the company's Web site.
- Danger: Counterfeit Serostim® (Human Growth Hormone)
A warning from the company and the FDA about a new counterfeit human growth hormone -- the second such case this year.
- June 23: New York March and Rally Before United Nations AIDS Session
A major rally will take place in New York, just before the opening of the United Nations General Assembly Special Session on AIDS (UNGASS). It is seeking funding, debt cancellation, and political will to make treatments available to save the lives of persons in developing countries with HIV.
- United Nations: Civil Society Snubbed at Final Preparatory Meeting on AIDS
Many of the AIDS organizers, some of whom traveled long distances at their own expense, found they had little input into preparations for the United Nations AIDS session in June.
- Global AIDS: Back to the Past?
We believe the potential availability of affordable treatment in Africa transformed AIDS from an unsolvable tragedy to an opportunity to save lives, making mobilization possible. But in the last few weeks, a push to avoid funding treatment in order to focus on prevention weakened the momentum against AIDS as a whole.
ISSN # 1052-4207
Copyright 2001 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.